Clinical trial
Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
NCT04061746 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
- Lead sponsor
- Medical University of South Carolina
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- February 27, 2020
- Completion date
- May 30, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.